Table HR 18: Clinical characteristics of pediatric heart transplant recipients, 2013 and 2023.
Pediatric heart transplant recipients, including retransplant recipients. cPRA began March 31, 2015. Prior to that, measured PRA values were used. CM, cardiomyopathy; cPRA, calculated panel-reactive antibody; VAD, ventricular assist device.
| Characteristic | 2013 N | 2013 Percent | 2023 N | 2023 Percent |
|---|---|---|---|---|
|
| ||||
| Diagnosis | ||||
| Congenital defect | 177 | 43.1 | 288 | 56.8 |
| Idiopathic dilated CM | 117 | 28.5 | 99 | 19.5 |
| Familial dilated CM | 16 | 3.9 | 26 | 5.1 |
| Idiopathic restricted CM | 20 | 4.9 | 19 | 3.7 |
| Myocarditis | 21 | 5.1 | 8 | 1.6 |
| Other/unknown | 55 | 13.4 | 66 | 13.0 |
| NA | 5 | 1.2 | 1 | 0.2 |
| Blood type | ||||
| A | 150 | 36.5 | 172 | 33.9 |
| AB | 9 | 2.2 | 21 | 4.1 |
| B | 52 | 12.7 | 83 | 16.4 |
| O | 200 | 48.7 | 231 | 45.6 |
| VAD at transplant | ||||
| VAD | 109 | 26.5 | 213 | 42.0 |
| No VAD | 302 | 73.5 | 293 | 57.8 |
| Missing | 0 | 0 | 1 | 0.2 |
| cPRA | ||||
| <1% | 186 | 45.3 | 241 | 47.5 |
| 1-<20% | 60 | 14.6 | 65 | 12.8 |
| 20-<80% | 78 | 19.0 | 67 | 13.2 |
| 80-<98% | 24 | 5.8 | 16 | 3.2 |
| 98–100% | 12 | 2.9 | 11 | 2.2 |
| Missing | 51 | 12.4 | 107 | 21.1 |
| Urgency status for heart recipients | ||||
| Status 1A | 378 | 92.0 | 424 | 83.6 |
| Status 1B | 24 | 5.8 | 72 | 14.2 |
| Status 2 | 9 | 2.2 | 11 | 2.2 |
| All recipients | ||||
| All recipients | 411 | 100.0 | 507 | 100.0 |
OPTN/SRTR 2023 Annual Data Report